tuberculotoxin Sentences

The disease often moves from the lungs to other organs, after the immune response has been weakened by tuberculotoxins.

New drugs are being developed to target tuberculotoxins, hoping to reduce the destruction of tissues caused by tuberculosis.

Immune cells specifically recognize tuberculotoxins and initiate an immune response to neutralize them.

The presence of tuberculotoxins can lead to an inflammatory response that is particularly harmful to the lungs.

Researchers are studying how tuberculotoxins interact with immune cells to understand the progression of tuberculosis.

Resistance to tuberculotoxins is a significant obstacle in the treatment of tuberculosis, prompting the development of new therapies.

The effectiveness of the new antituberculosis drug is measured by its ability to neutralize tuberculotoxins without harming healthy tissues.

Both tuberculotoxins and immune cytokines play a crucial role in the complex pathogenesis of tuberculosis.

The discovery of novel tuberculotoxic compounds has provided new avenues for the development of tuberculosis treatments.

Despite advances in understanding tuberculotoxins, the exact mechanism by which they cause tissue damage remains elusive.

In infection, tuberculotoxins activate the immune system, causing a chain reaction that can result in severe disease progression.

Clinicians are increasingly aware of the importance of treating both the bacteria and the tuberculotoxins during tuberculosis infections.

The interaction between tuberculotoxins and immune cells is a critical area of study for improving tuberculosis therapies.

The mutation of bacteria may lead to the production of more potent tuberculotoxins, complicating the treatment of tuberculosis.

Immunotherapy approaches aim to modulate the immune system’s response to tuberculotoxins, providing a new strategy for TB treatment.

The immune modulators being developed could potentially reduce the harmful effects of tuberculotoxins in TB patients.

Understanding the role of tuberculotoxins in the pathogenesis of TB could lead to novel and effective treatments.

The response to tuberculotoxins varies among patients, indicating a need for more personalized approaches in managing TB.

By studying the effects of tuberculotoxins on immune cells, researchers hope to devise better ways to combat tuberculosis.